During the past decade, Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator, "Leiner Health Products" with 1 trials as a collaborator, "Mead Johnson Nutrition" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine" are "Atherosclerosis" (6 trials), "Coronary Artery Disease" (1 trials), "Diabetes Mellitus" (1 trials) and "Postmenopause" (1 trials). Many other conditions were trialed in "Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine" in a lesser frequency.

Most popular intervention types in "Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "17B-estradiol" (1 trials), "DL-alpha-tocopherol" (1 trials), "Micronized 17B-estradiol" (1 trials), "Placebo" (1 trials) and "folic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".